Epidemiology and Management of Metastatic Breast Cancer

AstraZeneca128 enrolled

Overview

This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.

Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study

Study Type

OBSERVATIONAL

Enrollment

128

Conditions

Breast Cancer Nos Metastatic Recurrent

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female aged 18 years and over Diagnosis of breast cancer according to ICD-10 diagnostic criteria with confirmed metastasis * Confirmed diagnosis between 1st July 2010 - 30th June 2011 * Female patient managed for her disease at the same setting where final diagnosis of MBC was performed Exclusion Criteria: * History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer)

Locations (15)

Doina Coste Gherasim

Baia Mare, Romania

Daniel Ciurescu

Brasov, Romania

Dana Lucia Stanculeanu

Bucharest, Romania

Outcomes

Primary Outcomes

The incidence rate of progression of disease in a cohort of patients newly diagnosed with MBC, either De Novo or having progressed from a non-metastatic stage

Time frame: At 12 and 18 months after diagnosis